|
1
|
Nagasue N, Chang YC, Hayashi T, Galizia G,
Kohno H, Nakamura T and Yukaya H: Androgen receptor in
hepatocellular carcinoma as a prognostic factor after hepatic
resection. Ann Surg. 209:424–427. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Okitsu K, Kanda T, Imazeki F, Yonemitsu Y,
Ray RB, Chang C and Yokosuka O: Involvement of interleukin-6 and
androgen receptor signaling in pancreatic cancer. Genes Cancer.
1:859–867. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jiang X, Kanda T, Nakamoto S, Miyamura T,
Wu S and Yokosuka O: Involvement of androgen receptor and
glucose-regulated protein 78 kDa in human hepatocarcinogenesis. Exp
Cell Res. 323:326–336. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rochefort H and Chalbos D: The role of sex
steroid receptors on lipogenesis in breast and prostate
carcinogenesis: A viewpoint. Horm Cancer. 1:63–70. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chiu CM, Yeh SH, Chen PJ, Kuo TJ, Chang
CJ, Chen PJ, Yang WJ and Chen DS: Hepatitis B virus X protein
enhances androgen receptor-responsive gene expression depending on
androgen level. Proc Natl Acad Sci USA. 104:2571–2578. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zheng Y, Chen WL, Ma WL, Chang C and Ou
JH: Enhancement of gene transactivation activity of androgen
receptor by hepatitis B virus X protein. Virology. 363:454–461.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kanda T, Steele R, Ray R and Ray RB:
Hepatitis C virus core protein augments androgen receptor-mediated
signaling. J Virol. 82:11066–11072. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ueda T, Bruchovsky N and Sadar MD:
Activation of the androgen receptor N-terminal domain by
interleukin-6 via MAPK and STAT3 signal transduction pathways. J
Biol Chem. 277:7076–7085. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gehlhaus M, Schmitt N, Volk B and Meyer
RP: Antiepileptic drugs affect neuronal androgen signaling via a
cytochrome P450-dependent pathway. J Pharmacol Exp Ther.
322:550–559. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yoon G, Kim JY, Choi YK, Won YS and Lim
IK: Direct activation of TGF-beta1 transcription by androgen and
androgen receptor complex in Huh7 human hepatoma cells and its
tumor in nude mice. J Cell Biochem. 97:393–411. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Krycer JR and Brown AJ: Cross-talk between
the androgen receptor and the liver X receptor: Implications for
cholesterol homeostasis. J Biol Chem. 286:20637–20647. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hao Q, Li T, Zhang X, Gao P, Qiao P, Li S
and Geng Z: Expression and roles of fatty acid synthase in
hepatocellular carcinoma. Oncol Rep. 32:2471–2476. 2014.PubMed/NCBI
|
|
13
|
Qiu JF, Zhang KL, Zhang XJ, Hu YJ, Li P,
Shang CZ and Wan JB: Abnormalities in plasma phospholipid fatty
acid profiles of patients with hepatocellular carcinoma. Lipids.
50:977–985. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koh WP, Dan YY, Goh GB, Jin A, Wang R and
Yuan JM: Dietary fatty acids and risk of hepatocellular carcinoma
in the Singapore Chinese health study. Liver Int. 36:893–901. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Litvinov IV, Chang C and Isaacs JT:
Molecular characterization of the commonly used human androgen
receptor expression vector, pSG5-AR. Prostate. 58:319–324. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schröder PC, Segura V, Riezu JI, Sangro B,
Mato JM, Prieto J, Santamaría E and Corrales FJ: A signature of six
genes highlights defects on cell growth and specific metabolic
pathways in murine and human hepatocellular carcinoma. Funct Integr
Genomics. 11:419–429. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Suto K, Kajihara-Kano H, Yokoyama Y,
Hayakari M, Kimura J, Kumano T, Takahata T, Kudo H and Tsuchida S:
Decreased expression of the peroxisomal bifunctional enzyme and
carbonyl reductase in human hepatocellular carcinomas. J Cancer Res
Clin Oncol. 125:83–88. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Meyer K, Lee JS, Dyck PA, Cao WQ, Rao MS,
Thorgeirsson SS and Reddy JK: Molecular profiling of hepatocellular
carcinomas developing spontaneously in acyl-CoA oxidase deficient
mice: Comparison with liver tumors induced in wild-type mice by a
peroxisome proliferator and a genotoxic carcinogen. Carcinogenesis.
24:975–984. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li J, Huang Q, Long X, Zhang J, Huang X,
Aa J, Yang H, Chen Z and Xing J: CD147 reprograms fatty acid
metabolism in hepatocellular carcinoma cells through
Akt/mTOR/SREBP1c and P38/PPARα pathways. J Hepatol. 63:1378–1389.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Muir K, Hazim A, He Y, Peyressatre M, Kim
DY, Song X and Beretta L: Proteomic and lipidomic signatures of
lipid metabolism in NASH-associated hepatocellular carcinoma.
Cancer Res. 73:4722–4731. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jin S, Chen J, Chen L, Histen G, Lin Z,
Gross S, Hixon J, Chen Y, Kung C, Chen Y, et al: ALDH2(E487K)
mutation increases protein turnover and promotes murine
hepatocarcinogenesis. Proc Natl Acad Sci USA. 112:9088–9093. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Honeyman JN, Simon EP, Robine N,
Chiaroni-Clarke R, Darcy DG, Lim II, Gleason CE, Murphy JM,
Rosenberg BR, Teegan L, et al: Detection of a recurrent
DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular
carcinoma. Science. 343:1010–1014. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sakabe T, Tsuchiya H, Kanki K, Azumi J,
Gonda K, Mizuta Y, Yamada D, Wada H, Shomori K, Nagano H and Shiota
G: Identification of the genes chemosensitizing hepatocellular
carcinoma cells to interferon-α/5-fluorouracil and their clinical
significance. PLoS One. 8:e561972013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ellis JM, Wong GW and Wolfgang MJ: Acyl
coenzyme A thioesterase 7 regulates neuronal fatty acid metabolism
to prevent neurotoxicity. Mol Cell Biol. 33:1869–1882. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zha S, Ferdinandusse S, Hicks JL, Denis S,
Dunn TA, Wanders RJ, Luo J, De Marzo AM and Isaacs WB: Peroxisomal
branched chain fatty acid beta-oxidation pathway is upregulated in
prostate cancer. Prostate. 63:316–323. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bolton EC, So AY, Chaivorapol C, Haqq CM,
Li H and Yamamoto KR: Cell- and gene-specific regulation of primary
target genes by the androgen receptor. Genes Dev. 21:2005–2017.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Baron A, Migita T, Tang D and Loda M:
Fatty acid synthase: A metabolic oncogene in prostate cancer? J
Cell Biochem. 91:47–53. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mounier C, Bouraoui L and Rassart E:
Lipogenesis in cancer progression (review). Int J Oncol.
45:485–492. 2014.PubMed/NCBI
|
|
30
|
Jiang J, Nilsson-Ehle P and Xu N:
Influence of liver cancer on lipid and lipoprotein metabolism.
Lipids Health Dis. 5:42006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Miyanari Y, Atsuzawa K, Usuda N, Watashi
K, Hishiki T, Zayas M, Bartenschlager R, Wakita T, Hijikata M and
Shimotohno K: The lipid droplet is an important organelle for
hepatitis C virus production. Nat Cell Biol. 9:1089–1097. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Meissner EG, Lee YJ, Osinusi A, Sims Z,
Qin J, Sturdevant D, McHutchison J, Subramanian M, Sampson M,
Naggie S, et al: Effect of sofosbuvir and ribavirin treatment on
peripheral and hepatic lipid metabolism in chronic hepatitis C
virus, genotype 1-infected patients. Hepatology. 61:790–801. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu YL, Peng XE, Zhu YB, Yan XL, Chen WN
and Lin X: Hepatitis B virus X protein induces hepatic steatosis by
enhancing the expression of liver fatty acid binding protein. J
Virol. 90:1729–1740. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Haga Y, Kanda T, Sasaki R, Nakamura M,
Nakamoto S and Yokosuka O: Nonalcoholic fatty liver disease and
hepatic cirrhosis: Comparison with viral hepatitis-associated
steatosis. World J Gastroenterol. 21:12989–12995. 2015. View Article : Google Scholar : PubMed/NCBI
|
